American Psychiatric Association

American Psychiatric Association. It is the world's largest psychiatric organization, representing over 38,000 psychiatrists. Founded in 1844, it is instrumental in setting professional standards, advancing psychiatric education and research, and advocating for patients and the profession. Its most influential contribution is the Diagnostic and Statistical Manual of Mental Disorders, the primary diagnostic guide used in the United States and globally.

History

The association was founded on October 16, 1844, by 13 superintendents of American asylums, including Thomas Story Kirkbride, meeting at the Jones Hotel in Philadelphia. Initially named the Association of Medical Superintendents of American Institutions for the Insane, it focused on improving conditions in mental hospitals. The organization was renamed the American Medico-Psychological Association in 1892 before adopting its current name in 1921. Key historical figures like Benjamin Rush, considered the "father of American psychiatry," and later leaders such as William C. Menninger helped shape its evolution from a custodial focus to a medical and scientific discipline. The post-war era saw a shift towards psychoanalysis and community-based care, influenced by the Community Mental Health Act and the deinstitutionalization movement.

Organization and governance

The association is governed by an elected Board of Trustees and led by a President who serves a one-year term; the current president is Petros Levounis. Its operations are managed by a Chief Executive Officer and staff at its headquarters in Washington, D.C.. The membership is organized into district branches across the United States and Canada, and includes various caucuses and assemblies representing different practice interests and demographic groups. Key components include the APA Foundation and the APA Publishing division.

Publications and resources

The association publishes numerous influential journals, most notably the American Journal of Psychiatry, one of the most widely read psychiatric journals globally, and Psychiatric News, its official newspaper. Through APA Publishing, it produces authoritative textbooks like the Kaplan & Sadock's Comprehensive Textbook of Psychiatry and clinical practice guides. It also provides extensive continuing medical education resources, board certification review materials, and the Mental Health Parity toolkit to support clinicians. Digital resources include the PsychiatryOnline platform, which hosts the DSM-5-TR and its entire publication catalog.

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders is the association's preeminent publication, serving as the standard classification of mental disorders in the United States. The first edition, DSM-I, was published in 1952, with major revisions including the DSM-III in 1980, which introduced a descriptive, symptom-based approach. The current editions are the DSM-5 and its text revision, DSM-5-TR, which are used by clinicians, researchers, insurers, and policymakers worldwide. The development process involves extensive field trials and input from numerous work groups of experts, though it has faced scrutiny regarding the influence of the pharmaceutical industry.

Positions and advocacy

The association actively advocates for policies to improve mental health care access and reduce stigma, championing legislation like the Mental Health Parity and Addiction Equity Act. It takes official positions on contemporary issues, having issued statements supporting marriage equality and opposing psychiatric torture. Its APA Political Action Committee (APAPAC) lobbies Congress on issues affecting psychiatric practice. The organization also engages in public education campaigns and collaborates with entities like the World Psychiatric Association and the National Institute of Mental Health to advance global mental health.

Controversies and criticism

The association has faced significant controversy, particularly regarding historical positions. Its classification of homosexuality as a mental disorder in the DSM-II was not removed until 1973 following protests by gay rights activists. Critics, including the Church of Scientology and the anti-psychiatry movement, have long accused it of over-medicalizing normal behavior and having overly close ties to Big Pharma. Debates persist around diagnostic expansions in successive DSM editions and the perceived medicalization of conditions like grief. Legal and ethical critiques have also focused on its past involvement with exploitative practices, as examined in reports like the Guttmacher Report on the Rosenhan experiment.